All articlesStudy of the product itself — weaker design
A before-and-after study: Proxeed Women and ICSI outcomes
The study compared a second ICSI cycle in women who took Proxeed Women for two months beforehand against their own first cycle without supplementation.
Reading mode
Key findings
- Oocyte maturation rate rose from 69% to 84%.
- Good-embryo rate rose from 40% to 65%.
- Blastocyst rate reached 45%, and top-quality blastocyst rate 45.2%.
What this study does not show
Before-and-after design with no randomisation and no control group, published as a conference abstract with limited detail. The outcomes are laboratory measures (oocytes and embryos), not pregnancy or live birth.
Key findings
- Oocyte maturation rate rose from 69% to 84%.
- Good-embryo rate rose from 40% to 65%.
- Blastocyst rate reached 45%, and top-quality blastocyst rate 45.2%.
- First-cycle fertilisation rate was 55% and cleavage rate 58%.
What this study does not show
Before-and-after design with no randomisation and no control group, published as a conference abstract with limited detail. The outcomes are laboratory measures (oocytes and embryos), not pregnancy or live birth.
Published source
- Comparison of ICSI results in a group of patients with and without oral L-carnitine, acetyl-L-carnitine and nutrients supplementation
- Oumaima G, Trabelsi N, Ghodhbene E, Bouhlel F, Mustapha H, Ajina M
- Medical Journal of Malaysia (MJM) — OGSM 2025 conference abstract · 2025
- Before-and-after study (conference abstract)